<DOC>
	<DOCNO>NCT00140790</DOCNO>
	<brief_summary>The purpose study investigate angiotensin II receptor blocker , valsartan 160 mg/day effective reduce incidence cardiovascular event compare 40 mg/day patient moderate renal dysfunction .</brief_summary>
	<brief_title>Valsartan Cardiovascular Disease With Renal Dysfunction ( The V-CARD ) Study</brief_title>
	<detailed_description>It well known patient renal dysfunction poor prognosis concern cardiovascular disease . That call `` cardiorenal syndrome '' . It report valsartan effective reduce urine albumin extraction rate patient hyper- normotension . We hypothesize valsartan effective prevent cardiovascular event intermediary improve renal function . The primary endpoint : - cardiovascular event ( cardiac death , non-fatal myocardial infarction , unstable angina require rehospitalization , congestive heart failure require rehospitalization , revascularization procedure include coronary angioplasty coronary artery bypass grafting ; Stroke transient ischaemic attack , dissociation aneurysm aorta need hospitalisation ; Lower limbs artery obstruction need hospitalisation . - end-stage renal dysfunction ( introduction hemodialysis kidney transplantation ) - 50 % reduction creatinine clearance The secondary endpoint : - systolic diastolic function leave ventricle estimate echocardiography ( % FS E/A ratio ) - specific biochemical marker cardiac renal function ( urine microalbumin , plasma B-type natriuretic peptide , plasma type 1 plasminogen activator inhibitor , plasma cystatin C ) - % change creatinine clearance start end study period - transition 1/ ( serum Cr ) patient whose u-prot/u-Cr equal 1.0 - transition serum K - HbA1c - New onset Atrial Fibrillation - New onset Diabetes</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Inclusion Criteria ( require ) : Systolic blood pressure ( SBP ) &gt; /= 140 and/or diastolic blood pressure ( DBP ) &gt; /= 90 ( untreated hypertension case ) ; SBP &gt; /=130 and/or DBP &gt; /=80 ( treat hypertension case ) Patients coronary artery disease ( 50 % stenosis coronary angiography [ CAG ] , coronary compute tomography [ CT ] coronary magnetic resonance angiography [ MRA ] ; coronary spasm ; history percutaneous coronary intervention [ PCI ] ) ; Unstable angina patient Creatinine clearance 30.0 89.9 ml/min Exclusion Criteria ( least one follow ) : Reduced leave ventricular ( LV ) function ( ejection fraction [ EF ] equal less 40 % ) Hyperpotassemia ( serum potassium equal 5.5 mEq/l ) Rapid progressive glomerular nephritis Nephrotic syndrome Renal artery stenosis Uncontrolled diabetes ( HbA1c equal 9.0 % ) History allergy valsartan Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Cardiorenal syndrome</keyword>
	<keyword>Renal dysfunction</keyword>
	<keyword>Cardiovascular event</keyword>
	<keyword>Valsartan</keyword>
</DOC>